LONDON (dpa-AFX) - Animal genetics company Genus Plc (GNS.L), on Thursday,
issued a trading update for the fiscal 2024 first half period of 1 July 2023 to
31 December 2023 and reported its resilient performance amidst challenging
market conditions.

PIC ex-China performed robustly with North America, Latin America, and Europe
delivering growth in adjusted operating profit in constant currency. Despite the
challenging porcine market in China, the company's enhanced commercial focus in
the period has led to winning new royalty customers. This achievement is
expected to have a positive impact on fiscal year 2025 and beyond.

In challenging markets, ABS saw volumes decrease 6%. Demand for dairy genetics
in China was particularly impacted due to a double-digit decline in the dairy
herd.

Given the current market condition, the company expects fiscal year 2024
adjusted profit before tax to be not less than £58 million in actual currency.
For the 2024 fiscal first half period, Genus projects revenue to be £334 million
and adjusted profit before tax of £29 million, in-line with expectations.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX